Mitsui Chemicals' starts new Singapore elastomers plant
Mitsui elastomers Singapore Pte. Ltd., has embarked upon the commercial operation of its new high-performance elastomers plant on Jurong Island, Singapore, MCI announced today.
MELS was established on February 7, 2001, with a paid-in capital of 35 million U.S. dollars and head offices in downtown Singapore, to engage in the manufacture and sale of a line of high-performance elastomers centered at the flagship product Tafmer®. Construction of the new plant which has been proceeding smoothly since the ground-breaking in September, 2001, was completed successfully in November 2002. Thereafter, test runs for confirming the plant integrity and product quality have been conducted successfully, while at the same time samples were distributed to customers for ascertaining product Tafmer®'s commercial viability. The plant, with a production capacity of 100,000 ton/yr, is a largest-class world-scale elastomers plant fully leveraging MCI's latest production technology based on the company's many years of outstanding capabilities in the polymers field.
Other news from the department business & finance
These products might interest you
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
Spinsolve Benchtop NMR by Magritek
Spinsolve Benchtop NMR
Spinsolve is a revolutionary multinuclear NMR spectrometer that provides the best performance
HYPERION II by Bruker
FT-IR and IR laser imaging (QCL) microscope for research and development
Analyze macroscopic samples with microscopic resolution (5 µm) in seconds
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
